Smartphone and wearable tools can track and support real-world movement in people with MS, helping spot mobility changes earlier and guide care.
Researchers reviewed how mobile health (mHealth) tools — like phones and fitness trackers — can measure everyday movement in people with MS. These tools can capture real-life walking, balance, and activity patterns, not just what happens in a clinic, similar to watching someone at home instead of only in a short doctor visit. Certain movement measurements from these devices can show small declines in mobility that might be missed during a clinic checkup, like noticing a slow but steady drop in daily steps. The review explains that these real-world measures could help doctors track MS progression and decide if treatments or therapy need to change. Finally, mHealth can also be used to support people with MS by reminding, guiding, or motivating them to move safely and stay active, like a gentle coach on your wrist or phone.
People with MS should care because mHealth can give a more complete picture of how mobility is changing day to day, not just during rare clinic visits — think of it like a continuous diary of movement. Caregivers can use this information to spot changes sooner, so they can help arrange care, therapy, or safety measures before problems get worse. Healthcare providers benefit because objective, real-world data can improve decisions about treatment, therapy plans, or when to adjust medications. Rehabilitation therapists can tailor exercise or balance programs based on actual daily movement patterns, not only test results from the clinic. Overall, this can affect daily life by identifying early warning signs (for example, fewer steps or more frequent pauses while walking) so timely steps — like home exercise, assistive devices, or medication review — can be taken to reduce falls and preserve independence.
Most evidence so far is from studies that review tools and early research, not large long-term trials, so we don’t yet know exactly how best to use mHealth in every situation. Devices and apps can vary in accuracy, and not every tracker measures the same things, which means results should be interpreted with caution. Using these tools also requires access to and comfort with technology, so they may not be equally helpful for everyone; discuss options with your care team before relying on them.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Exercise and sport sciences reviews often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.